Sino Biological released its performance for the first three quarters, with a net profit attributable to the parent company of 110 million yuan, an increase of 10.94%
According to the Zhitong Finance APP, Sino Biological released its third-quarter report for 2025. The company's operating income for the first three quarters was 511 million yuan, a year-on-year increase of 10.00%. The net profit attributable to shareholders of the listed company was 110 million yuan, a year-on-year increase of 10.94%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 62.2531 million yuan, a year-on-year increase of 75.30%. The basic earnings per share were 0.9058 yuan
According to the Zhitong Finance APP, Sino Biological (301047.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 511 million yuan, a year-on-year increase of 10.00%. The net profit attributable to shareholders of the listed company was 110 million yuan, a year-on-year increase of 10.94%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 62.2531 million yuan, a year-on-year increase of 75.30%. The basic earnings per share were 0.9058 yuan
